2021
DOI: 10.1007/s12928-021-00796-1
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence and prognosis of isolated posterior ST-segment elevation acute myocardial infarction using synthesized-V7–9 lead

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 21 publications
0
4
0
Order By: Relevance
“…A recent study in 2021 by Shimojo et al . suggested that the V7–V9 lead helps diagnose IPMI and might improve the prognosis [ 16 ]. However, IPMI is still a rare occurrence that remains underdiagnosed [ 15 ].…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…A recent study in 2021 by Shimojo et al . suggested that the V7–V9 lead helps diagnose IPMI and might improve the prognosis [ 16 ]. However, IPMI is still a rare occurrence that remains underdiagnosed [ 15 ].…”
Section: Discussionmentioning
confidence: 99%
“… Prevalence and prognosis of isolated posterior ST-segment elevation acute myocardial infarction using synthesized-V7–9 lead Shimojo et al . 2021 [ 16 ] 10 patients Among 142 consecutive patients with STEMI with the culprit lesion on LCx, 10 patients (7.0%) had ST elevation only in synthesized V7–V9 lead who classified as STEMI-LCx-synV7–V9 group and the remaining as STEMI-LCx-12ECG group [132 patients (93%)] The patients with STEMI-LCx-synV7–V9 had significantly higher incidences of cardiac death within 3 months and 1 year (30.0% versus 6.1%, p = 0.031, 30.0% versus 7.6%, p = 0.050, respectively) and mechanical complications in each follow-up period (20.0% versus 1.5 %, p = 0.025) than those with STEMI-LCx-12ECG …”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations